CLINIGENCE HOLDINGS, INC. – Trademark Portfolio
Entity Type: 03
CLINIGENCE HOLDINGS, INC. holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 4 filings in this category. The portfolio also extends into Class 35 (Advertising & Business) across 3 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include CLINIGENCE and QUALMETRIX. The owner is based in ATLANTA, GA.
55 IVAN ALLEN JR. BLVD., SUITE 875
ATLANTA, GA 30308
Showing of trademarks Trademarks
Trademark Classifications
CLINIGENCE HOLDINGS, INC.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Advertising; business management; business administration; office functions
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Frequently Asked Questions
How many trademarks does CLINIGENCE HOLDINGS, INC. have?
CLINIGENCE HOLDINGS, INC. has 4 U.S. trademarks filed with the USPTO. Of these, 2 registered, 2 abandoned.
What trademark classes does CLINIGENCE HOLDINGS, INC. file in?
CLINIGENCE HOLDINGS, INC. files trademarks across 3 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 35 (Advertising & Business), Class 44 (Medical Services). Class 42 covers scientific and technological services; industrial analysis and research services.
What are CLINIGENCE HOLDINGS, INC.'s most well-known trademarks?
CLINIGENCE HOLDINGS, INC.'s registered trademark portfolio includes well-known marks such as CLINIGENCE and QUALMETRIX. These are among 2 currently registered trademarks in the portfolio.
What is CLINIGENCE HOLDINGS, INC.'s trademark registration success rate?
CLINIGENCE HOLDINGS, INC. has a 50% trademark registration rate, with 2 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.